ASMB Quote, Trading Chart, Assembly Biosciences Inc.
home / stock / asmb / asmb quote
$4.01 Last:
-1.23% Change Percent:
$4.06 Open:
$4.01 Previous Close:
$4.09 High:
$3.92 Low:
1,779,416 Volume:
06/21/2021 04:42:38 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
ASMB Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 4.06 | 4.01 | 4.09 | 3.92 | 1,779,416 |
| 2021-06-18 | 4.16 | 4.06 | 4.18 | 4.04 | 1,217,124 |
| 2021-06-17 | 4.11 | 4.17 | 4.26 | 4.03 | 2,459,623 |
| 2021-06-16 | 4.1426 | 4.11 | 4.1501 | 4.03 | 1,127,550 |
| 2021-06-15 | 4.27 | 4.12 | 4.28 | 4.0699 | 1,256,819 |
| 2021-06-14 | 4.3821 | 4.25 | 4.3821 | 4.18 | 1,827,128 |
| 2021-06-11 | 4.55 | 4.38 | 4.69 | 4.34 | 2,613,820 |
| 2021-06-10 | 4.37 | 4.46 | 4.62 | 4.32 | 3,645,748 |
| 2021-06-09 | 4.12 | 4.34 | 4.36 | 4.12 | 1,817,193 |
| 2021-06-08 | 4.06 | 4.1 | 4.17 | 4.04 | 771,173 |
| 2021-06-07 | 3.89 | 4.04 | 4.0641 | 3.87 | 785,533 |
| 2021-06-04 | 3.93 | 3.86 | 3.99 | 3.86 | 501,733 |
| 2021-06-03 | 3.96 | 3.93 | 3.96 | 3.8575 | 498,902 |
| 2021-06-02 | 3.99 | 3.94 | 4.03 | 3.91 | 761,368 |
| 2021-06-01 | 4 | 4.03 | 4.04 | 3.93 | 702,572 |
| 2021-05-31 | 4.03 | 3.97 | 4.11 | 3.97 | 434,884 |
| 2021-05-28 | 4.03 | 3.97 | 4.11 | 3.97 | 433,844 |
| 2021-05-27 | 3.89 | 3.95 | 4.06 | 3.88 | 1,302,860 |
| 2021-05-26 | 3.83 | 3.87 | 3.89 | 3.78 | 425,057 |
| 2021-05-25 | 3.88 | 3.8 | 3.9086 | 3.8 | 864,585 |
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced that three abstracts have been accepted for presentation dur...
-
SOUTH SAN FRANCISCO, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced that Lisa Johnson-Pratt, M.D., has joined the company’...
-
Assembly Biosciences (NASDAQ: ASMB) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We are updating our model post the 1Q21 print (no major changes, PT still $13). The stock hit a new all-time low last night, closing at $3.9...